Revenue Growth Driving Group to Record EBITDA • Revenue of $186.5 million with organic revenue growth of 6.2% • Record Adjusted EBITDA of $45.4 ...
ZELSUVMI™ net product revenue grew 28% Quarter over Quarter to $9.1 million, bringing total ZELSUVMI net product revenue to $16.2 million, for ...
Total revenue including licensing revenue was $16.8 million for 2025. 8,948 ZELSUVMI units prescribed by 2,712 unique prescribers for fiscal year 2025, with a 129% quarter over quarter increase in ...
Experience the vision of Nobel Prize–winning innovators at the ACS Spring Meeting, with Dr. Jennifer Doudna, Priestley Medalist, Dr. Moungi Bawendi, and Dr. Omar Yaghi. A celebration of insight, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results